Shandong New Time Pharmaceutical Co., Ltd

Researchers are testing an experimental injectable drug called F182112 in adults with systemic lupus erythematosus. The drug is a bispecific antibody designed to guide the immune system to attack B cells and plasma cells that carry a marker called BCMA. The trial's main goal is t…

This trial is testing whether adding an experimental drug called F520 to standard chemotherapy (paclitaxel plus carboplatin) helps people with cancer of unknown primary — a cancer that has spread but whose original site cannot be found. About 402 adults aged 18 to 75 who have not…

This study tests a new drug called F182112 against standard treatments in 261 adults with multiple myeloma that has returned or stopped responding to prior therapies. The goal is to see if the new drug can delay cancer growth longer than usual care. Participants must have already…

This study tests a new drug called F182112 given with different treatment plans for people whose multiple myeloma has returned or stopped responding to prior therapies. About 90 participants will receive the drug combination to see if it shrinks tumors and how safe it is. The goa…